1. 11. Chronic kidney disease and risk management: standards of medical care in Diabetes-2022 [published correction appears in Diabetes Care. 2022;45(3):758];Diabetes Care,2022
2. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. http://kidneyfoundation.cachefly.net/professionals/KDOQI/guideline_diabetes/index.htm. Accessed May 23, 2022.
3. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies;Coresh;Lancet Diabetes Endocrinol,2019
4. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials;Heerspink;Lancet Diabetes Endocrinol,2019
5. Sodium-glucose cotransporter-2 inhibitors for type 2 diabetes mellitus in adults: an overview of 46 systematic reviews;Augusto;Diabetes Obes Metab,2021